A402420 Stock Overview
CALTH. Inc manufactures and sells diagnostic tests and analyzers in South Korea.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
CALTH. Inc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩12,920.00 |
| 52 Week High | ₩17,000.00 |
| 52 Week Low | ₩9,800.00 |
| Beta | 0 |
| 1 Month Change | -10.84% |
| 3 Month Change | -13.58% |
| 1 Year Change | 3.36% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -15.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| A402420 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | -4.2% | 2.7% | 2.2% |
| 1Y | 3.4% | 31.2% | 5.4% |
Return vs Industry: A402420 underperformed the KR Medical Equipment industry which returned 31.2% over the past year.
Return vs Market: A402420 underperformed the KR Market which returned 5.4% over the past year.
Price Volatility
| A402420 volatility | |
|---|---|
| A402420 Average Weekly Movement | 11.4% |
| Medical Equipment Industry Average Movement | 6.3% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 11.7% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A402420 has not had significant price volatility in the past 3 months.
Volatility Over Time: A402420's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | n/a | n/a | www.thecalth.com |
CALTH. Inc manufactures and sells diagnostic tests and analyzers in South Korea. It offers point of care testing, self-testing, and precision diagnosis based on ion concentration polarization technology.
CALTH. Inc Fundamentals Summary
| A402420 fundamental statistics | |
|---|---|
| Market cap | ₩28.77b |
| Earnings (TTM) | ₩0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs A402420 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A402420 income statement (TTM) | |
|---|---|
| Revenue | ₩0 |
| Cost of Revenue | ₩0 |
| Gross Profit | ₩0 |
| Other Expenses | ₩0 |
| Earnings | ₩0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did A402420 perform over the long term?
See historical performance and comparison